If a doctor diagnoses someone with Alzheimer’s disease, it is often too late. The condition has progressed too far to be treated. The scientists Dr. Philip Scheltens of the Amsterdam University Medical Center (UMC) in the Netherlands and Dr. Klaus Gerwert of the Ruhr University of Bochum (RUB), Germany, are working on a blood test that will make an early diagnosis possible. Partly thanks to the support of the Alzheimer Netherlands foundation, they will now able to continue working on this project for another two years. It involves the detection of bio-marker proteins, which are typical of Alzheimer’s disease. On average, blood tests can already point to Alzheimer’s disease eight years before the clinical diagnosis.
Get full access to our archive by becoming a member of Innovation Origins. Sign up here as a supporter of independent journalism!
Become a member!
On Innovation Origins you can read the latest news about the world of innovation every day. We want to keep it that way, but we can't do it alone! Are you enjoying our articles and would you like to support independent journalism? Become a member and read our stories guaranteed ad-free.